STOCK TITAN

[Form 4] ACM Research, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Insider activity at ACM Research (ACMR): Senior Vice President Sotheara Cheav exercised a stock option on 09/18/2025 to buy 10,000 shares of Class A common stock at an exercise price of $13.89 per share and simultaneously sold 10,000 shares at $35.00 per share under a Rule 10b5-1 trading plan adopted May 15, 2025. Following these transactions the reporting person beneficially owns 100,002 shares and holds options covering 56,250 underlying shares, with a portion of those options vesting through May 2026 and monthly thereafter. The Form 4 was signed on 09/19/2025 by an attorney-in-fact.

Attività di insider presso ACM Research (ACMR): Il vicepresidente senior Sotheara Cheav ha esercitato un’opzione su azioni il 18/09/2025 per acquistare 10.000 azioni ordinarie di Classe A a un prezzo di esercizio di 13,89 USD per azione e, contemporaneamente, ha venduto 10.000 azioni a 35,00 USD per azione secondo un piano di trading Rule 10b5-1 adottato il 15 maggio 2025. A seguito di queste operazioni la persona che segnala detiene utilmente 100.002 azioni e possiede opzioni su 56.250 azioni sottostanti, con una parte di queste opzioni che vanno in vesting entro maggio 2026 e mensilmente in seguito. Il Form 4 è stato firmato il 19/09/2025 da un procuratore-in-fact.

Actividad de insider en ACM Research (ACMR): El vicepresidente senior Sotheara Cheav ejerció una opción de compra de acciones el 18/09/2025 para adquirir 10,000 acciones ordinarias de Clase A a un precio de ejercicio de 13,89 USD por acción y, al mismo tiempo, vendió 10,000 acciones a 35,00 USD por acción conforme a un plan de negociación Rule 10b5-1 adoptado el 15 de mayo de 2025. Después de estas operaciones, la persona reportante posee beneficiosamente 100.002 acciones y mantiene opciones sobre 56.250 acciones subyacentes, con una parte de esas opciones que vesting hasta mayo de 2026 y mensualmente después. El Formulario 4 fue firmado el 19/09/2025 por un apoderado.

ACMR의 내부자 활동: 수석 부사장 소테라 차브가 2025년 9월 18일에 클래스 A 보통주 10,000주를 주당 13.89달러의 행사 가격으로 매수하기 위한 주식매수선택권을 행사했으며, 동시에 2025년 5월 15일에 채택된 Rule 10b5-1 트레이딩 계획에 따라 주당 35.00달러에 10,000주를 매도했습니다. 이 거래 후 보고자는 실질적으로 100,002주를 보유하고 있으며, 기초 주식 56,250주에 대한 옵션을 보유하고 있습니다. 이 옵션의 일부는 2026년 5월까지 vesting되고 그 이후로 매월 vesting됩니다. Form 4는 2025년 9월 19일 대리인에 의해 서명되었습니다.

Activité d’initiés chez ACM Research (ACMR) : Le vice-président principal Sotheara Cheav a exercé une option d’achat d’actions le 18/09/2025 pour acheter 10 000 actions ordinaires de classe A à un prix d’exercice de 13,89 USD par action et, simultanément, a vendu 10 000 actions à 35,00 USD par action dans le cadre d’un plan de trading Rule 10b5-1 adopté le 15 mai 2025. À la suite de ces opérations, la personne déclarant détient effectivement 100 002 actions et détient des options couvrant 56 250 actions sous-jacentes, une partie de ces options étant acquise jusqu’en mai 2026 et mensuellement par la suite. Le Formulaire 4 a été signé le 19/09/2025 par un mandataire.

Insideraktivität bei ACM Research (ACMR): Der Senior Vice President Sotheara Cheav hat am 18.09.2025 eine Aktienoption ausgeübt, um 10.000 Stammaktien der Klasse A zu einem Ausübungspreis von 13,89 USD je Aktie zu kaufen, und gleichzeitig 10.000 Aktien zu 35,00 USD pro Aktie im Rahmen eines Rule 10b5-1-Handelsplans verkauft, der am 15. Mai 2025 eingeführt wurde. Nach diesen Transaktionen besitzt die meldende Person vorteilhaft 100.002 Aktien und hält Optionen auf 56.250 zugrunde liegende Aktien, von denen ein Teil dieser Optionen bis Mai 2026 vestet und danach monatlich. Das Form 4 wurde am 19.09.2025 von einem Prokuristen unterzeichnet.

نشاط داخلي لدى ACM Research (ACMR): قام نائب الرئيس الأول سُثيرارا تشاف بممارسة خيار شراء أسهم في 18/09/2025 لشراء 10,000 سهم من أسهم الفئة أ العادية بسعر تنفيذ قدره 13.89 دولار للسهم وفي الوقت نفسه باع 10,000 سهم بسعر 35.00 دولار للسهم وفق خطة تداول Rule 10b5-1 المعتمدة في 15 مايو 2025. بعد هذه المعاملات يمتلك الشخص المبلغ عنه فعلياً 100,002 سهم ويملك خيارات تغطي 56,250 سهمًا أساسيًا، مع جزء من هذه الخيارات يتسارع vesting حتى مايو 2026 وبعد ذلك شهرياً. تم توقيع النموذج Form 4 في 19/09/2025 بواسطة وكيل.

ACM Research(ACMR)内部人活动: 高级副总裁Sotheara Cheav 于2025年9月18日行使股票期权,以每股13.89美元的行使价购买10,000股A类普通股,并同时按于2025年5月15日通过的Rule 10b5-1交易计划以每股35.00美元出售10,000股。完成这些交易后,申报人实际拥有100,002股,并持有覆盖56,250股基础股票的期权,其中部分期权将于2026年5月前 vesting,随后按月 vesting。Form 4于2025年9月19日由代理签署。

Positive
  • Reporting compliance: The Form 4 discloses exercise, sale, 10b5-1 plan date, and remaining holdings.
  • Ongoing ownership: Reporting person continues to beneficially own 100,002 shares and holds options for 56,250 shares.
Negative
  • Share disposition: 10,000 shares were sold, reducing immediate shareholdings.
  • Potential liquidity move: The sale was executed under a 10b5-1 plan, indicating the transaction may have been pre-arranged rather than opportunistic trading.

Insights

TL;DR: Insider exercised options and sold the same number of shares via a pre-established 10b5-1 plan; residual ownership remains meaningful.

The reporting person exercised 10,000 options at $13.89 and sold 10,000 shares at $35.00 on the same date, consistent with a Rule 10b5-1 plan adopted May 15, 2025. Such transactions commonly reflect routine liquidity or tax planning rather than new information about the company's operations. Post-transaction beneficial ownership is 100,002 shares and the reporting person retains options to acquire 56,250 shares, some of which vest through 2026 and thereafter.

TL;DR: Disclosure is compliant and includes required vesting and plan details; no material governance concerns evident.

The Form 4 discloses exercise, sale, Rule 10b5-1 adoption date, and remaining derivative holdings, which aligns with standard disclosure practices. The filing notes the reporting person’s officer role and subsidiary employment. There is no indication of accelerated vesting or related-party transactions in the filing text provided.

Attività di insider presso ACM Research (ACMR): Il vicepresidente senior Sotheara Cheav ha esercitato un’opzione su azioni il 18/09/2025 per acquistare 10.000 azioni ordinarie di Classe A a un prezzo di esercizio di 13,89 USD per azione e, contemporaneamente, ha venduto 10.000 azioni a 35,00 USD per azione secondo un piano di trading Rule 10b5-1 adottato il 15 maggio 2025. A seguito di queste operazioni la persona che segnala detiene utilmente 100.002 azioni e possiede opzioni su 56.250 azioni sottostanti, con una parte di queste opzioni che vanno in vesting entro maggio 2026 e mensilmente in seguito. Il Form 4 è stato firmato il 19/09/2025 da un procuratore-in-fact.

Actividad de insider en ACM Research (ACMR): El vicepresidente senior Sotheara Cheav ejerció una opción de compra de acciones el 18/09/2025 para adquirir 10,000 acciones ordinarias de Clase A a un precio de ejercicio de 13,89 USD por acción y, al mismo tiempo, vendió 10,000 acciones a 35,00 USD por acción conforme a un plan de negociación Rule 10b5-1 adoptado el 15 de mayo de 2025. Después de estas operaciones, la persona reportante posee beneficiosamente 100.002 acciones y mantiene opciones sobre 56.250 acciones subyacentes, con una parte de esas opciones que vesting hasta mayo de 2026 y mensualmente después. El Formulario 4 fue firmado el 19/09/2025 por un apoderado.

ACMR의 내부자 활동: 수석 부사장 소테라 차브가 2025년 9월 18일에 클래스 A 보통주 10,000주를 주당 13.89달러의 행사 가격으로 매수하기 위한 주식매수선택권을 행사했으며, 동시에 2025년 5월 15일에 채택된 Rule 10b5-1 트레이딩 계획에 따라 주당 35.00달러에 10,000주를 매도했습니다. 이 거래 후 보고자는 실질적으로 100,002주를 보유하고 있으며, 기초 주식 56,250주에 대한 옵션을 보유하고 있습니다. 이 옵션의 일부는 2026년 5월까지 vesting되고 그 이후로 매월 vesting됩니다. Form 4는 2025년 9월 19일 대리인에 의해 서명되었습니다.

Activité d’initiés chez ACM Research (ACMR) : Le vice-président principal Sotheara Cheav a exercé une option d’achat d’actions le 18/09/2025 pour acheter 10 000 actions ordinaires de classe A à un prix d’exercice de 13,89 USD par action et, simultanément, a vendu 10 000 actions à 35,00 USD par action dans le cadre d’un plan de trading Rule 10b5-1 adopté le 15 mai 2025. À la suite de ces opérations, la personne déclarant détient effectivement 100 002 actions et détient des options couvrant 56 250 actions sous-jacentes, une partie de ces options étant acquise jusqu’en mai 2026 et mensuellement par la suite. Le Formulaire 4 a été signé le 19/09/2025 par un mandataire.

Insideraktivität bei ACM Research (ACMR): Der Senior Vice President Sotheara Cheav hat am 18.09.2025 eine Aktienoption ausgeübt, um 10.000 Stammaktien der Klasse A zu einem Ausübungspreis von 13,89 USD je Aktie zu kaufen, und gleichzeitig 10.000 Aktien zu 35,00 USD pro Aktie im Rahmen eines Rule 10b5-1-Handelsplans verkauft, der am 15. Mai 2025 eingeführt wurde. Nach diesen Transaktionen besitzt die meldende Person vorteilhaft 100.002 Aktien und hält Optionen auf 56.250 zugrunde liegende Aktien, von denen ein Teil dieser Optionen bis Mai 2026 vestet und danach monatlich. Das Form 4 wurde am 19.09.2025 von einem Prokuristen unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Cheav Sotheara

(Last) (First) (Middle)
C/O ACM RESEARCH, INC.
42307 OSGOOD ROAD, SUITE I

(Street)
FREMONT CA 94539

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ACM Research, Inc. [ ACMR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See remarks
3. Date of Earliest Transaction (Month/Day/Year)
09/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 09/18/2025 M(1) 10,000 A $13.89 110,002 D
Class A Common Stock 09/18/2025 S(2) 10,000 D $35 100,002 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $13.89 09/18/2025 M(1) 10,000 (3) 08/09/2033 Class A Common Stock 10,000 $0 56,250 D
Explanation of Responses:
1. On September 18, 2025, the reporting person exercised a previously issued stock option to purchase 10,000 shares of Class A Common Stock of the Issuer.
2. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2025.
3. The option will vest and become exercisable as to 7,500 shares on May 15, 2026 and the remaining 22,500 shares will vest and become exercisable in equal monthly installments over the following 36 months, subject to continued service through each vesting date. option is fully vested and exercisable.
Remarks:
Senior Vice President, Manufacturing of ACM Research (Shanghai), Inc., a subsidiary of the Issuer.
/s/ Mark McKechnie, Attorney-in-Fact for Sotheara Cheav 09/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the ACMR insider do on 09/18/2025?

The reporting person exercised 10,000 options at $13.89 per share and sold 10,000 shares at $35.00 per share on 09/18/2025.

How many ACMR shares does the insider own after the transactions?

After the reported transactions the insider beneficially owns 100,002 shares of ACM Research.

Does the filing mention a trading plan for the sale?

Yes. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2025.

What derivative holdings does the insider retain?

The insider holds options covering 56,250 underlying shares; portions vest on May 15, 2026 and thereafter in monthly installments.

What is the reporting person’s role at ACMR?

The filing identifies the reporting person as Senior Vice President, Manufacturing of ACM Research (Shanghai), Inc.
Acm Research

NASDAQ:ACMR

ACMR Rankings

ACMR Latest News

ACMR Latest SEC Filings

ACMR Stock Data

2.32B
49.89M
15.04%
70.31%
6.43%
Semiconductor Equipment & Materials
Special Industry Machinery, Nec
Link
United States
FREMONT